Seminars in Fetal & Neonatal Medicine
Volume 15, Issue 5 , Pages 299-304, October 2010

Ethics and hypothermia treatment

  • John S. Wyatt

      Affiliations

    • Corresponding Author InformationTel.: +44 20 8800 3018; fax: +44 20 7679 6103.

Institute for Women's Health, University College London, 5 University Street, London WC1E 6JJ, UK

published online 12 April 2010.

Summary 

Hypothermia is the first effective neuroprotective intervention for newborns who are critically ill following a life-threatening asphyxial insult. It is not surprising that it has raised complex and controversial ethical dilemmas for investigators and clinicians. Given the history of iatrogenic disasters in neonatology, there has been an understandable reluctance to incorporate hypothermia into routine clinical practice until there is persuasive evidence from high quality randomised trials. This article reviews ethical issues that arose during the design of the original clinical trials, the implications of accumulating evidence of safety and efficacy, and the problems of ensuring informed parental participation in treatment decisions.

Keywords: Clinical decision-making, Informed consent, Neonatal encephalopathy, Therapeutic hypothermia, Withdrawal of treatment

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1744-165X(10)00016-8

doi:10.1016/j.siny.2010.03.002

Seminars in Fetal & Neonatal Medicine
Volume 15, Issue 5 , Pages 299-304, October 2010